High-affinity choline Uptake (HACU) in the Cortex, Striatum, and Hippocampus of non-tumor and tumor-bearing mice. by Robert Botelho (20308297)

Subjects:

Comparative death probabilities of tumor-bearing mice across weeks of assessment. by Robert Botelho (20308297)

Subjects:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

Velar adhesion (VA). by Miki Kashiwagi (21439684)

Subjects:

Death probabilities of tumor-bearing mice across weeks of assessment. by Robert Botelho (20308297)

Subjects:

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. by Miki Kashiwagi (21439684)

Subjects:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

MWM training data. by Robert Botelho (20308297)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Table 1_Associations between sleep changes and multimorbidity patterns in middle-aged and older Chinese adults.docx by Shuting Yin (9212536)

“…</p>Results<p>Five multimorbidity patterns were identified: relatively healthy class (55.41%), metabolism class (23.22%), arthritis-digestive class (10.67%), respiratory class (5.42%), multi-system morbidity class (5.28%). Sleep duration decreases of ≥1.0 h were significantly associated with higher odds of overall multimorbidity and specific multimorbidity patterns, particularly metabolism, arthritis-digestive, respiratory, and multi-system morbidity classes (FDR-p < 0.05). …”

Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors. by Mehran Asadi-Aliabadi (8383110)

Subjects: